 | • レポートコード：TPM-C03104 • 出版社/出版日：Transparency Market Research / 2019年2月14日 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、輸血技術の世界市場について調べ、輸血技術の世界規模、市場動向、市場環境、製品別（器具、使い捨て・消耗品）分析、エンドユーザー（病院、血液バンク、バイオテクノロジー企業・製薬会社）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・輸血技術の世界市場動向 ・輸血技術の世界市場環境 ・輸血技術の世界市場規模 ・輸血技術の世界市場規模：製品別（器具、使い捨て・消耗品） ・輸血技術の世界市場規模：エンドユーザー（病院、血液バンク、バイオテクノロジー企業・製薬会社） ・輸血技術の世界市場：地域別市場規模・分析 ・輸血技術の北米市場規模・予測 ・輸血技術のアメリカ市場規模・予測 ・輸血技術の中南米市場規模・予測 ・輸血技術のヨーロッパ市場規模・予測 ・輸血技術のアジア市場規模・予測 ・輸血技術の日本市場規模・予測 ・輸血技術の中国市場規模・予測 ・輸血技術のインド市場規模・予測 ・輸血技術の中東市場規模・予測 ・輸血技術のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Transfusion Technology Market – Overview
This report studies the current as well as future prospects of the global transfusion technology market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of transfusion technology and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global transfusion technology market in terms of product, end-user, and region.
The global transfusion technology market has been segmented based on product, end-user, and region. In terms of product, the global market has been classified into instruments and disposables & consumables. The instruments segment has been further bifurcated into apheresis system & multicomponent collection systems, cell processing systems & cell expansion systems, auto transfusion devices, and others. The others segment includes tube sealing system, sterile tubing welder, mixer technology, and point of care hemoglobin meters. Based on end-user, the global transfusion technology market has been segregated into hospitals, blood banks, biotechnology & pharmaceutical companies, and others. The blood banks segment is expected to dominate the global transfusion technology market during the forecast period.
Top-down approach has been employed for determining the size of the global transfusion technology market, using various market indicators obtained from secondary sources, which included analysis of launched products and mapping of demand for transfusion technology of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein market size of parent market was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market value and forecast, in terms of US$ Mn, for each segment has been provided for the period from 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
The overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have significant impact on the global transfusion technology market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across regions. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global transfusion technology market. The report also comprises technological advancement overview.
In terms of region, the global transfusion technology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section.
Major players operating in the global transfusion technology market are Haemonetics Corporation, Inc., Medtronic plc, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi AG (Fresenius SE & Co. KGaA), GE Healthcare, Miltenyi Biotec, TERUMO BCT, and LivaNova PLC. The global transfusion technology market has been segmented as follows:
Global Transfusion Technology Market, by Product
Instruments
Apheresis System & Multicomponent Collection Systems
Cell Processing Systems & Cell Expansion Systems
Auto transfusion Devices
Others
Disposables & Consumables
Global Transfusion Technology Market, by End-user
Hospitals
Blood Banks
Biotechnology & Pharmaceutical Companies
Others
Global Transfusion Technology Market, by Region
North America
U.S
Canada
Europe
U.K
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Transfusion Technology
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transfusion Technology Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Technological Advancement in Apheresis System & Multi-Component Separator Systems
5.2. Key Trends of Transfusion Technology
6. Global Transfusion Technology Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Transfusion Technology Market Value Forecast, by Product, 2016–2026
6.3.1. Instruments
6.3.1.1. Apheresis System & Multicomponent Collection Systems
6.3.1.2. Cell Processing Systems & Cell Expansion Systems
6.3.1.3. Auto Transfusion Devices
6.3.1.4. Others
6.3.2. Disposables & Consumables
6.4. Global Transfusion Technology Market Attractiveness, by Product
7. Global Transfusion Technology Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Transfusion Technology Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals
7.3.2. Blood Banks
7.3.3. Biotechnology & Pharmaceutical Companies
7.3.4. Others
7.4. Global Transfusion Technology Market Attractiveness, by End-user
8. Global Transfusion Technology Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Transfusion Technology Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Transfusion Technology Market Attractiveness, by Region
9. North America Transfusion Technology Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Transfusion Technology Market Value Forecast, by Product, 2016–2026
9.2.1. Instruments
9.2.1.1. Apheresis System & Multicomponent Collection Systems
9.2.1.2. Cell Processing Systems & Cell Expansion Systems
9.2.1.3. Auto Transfusion Devices
9.2.1.4. Others
9.2.2. Disposables & Consumables
9.3. North America Transfusion Technology Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Blood Banks
9.3.3. Biotechnology & Pharmaceutical Companies
9.3.4. Others
9.4. North America Transfusion Technology Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Transfusion Technology Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Transfusion Technology Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Transfusion Technology Market Value Forecast, by Product, 2016–2026
10.2.1. Instruments
10.2.1.1. Apheresis System & Multicomponent Collection Systems
10.2.1.2. Cell Processing Systems & Cell Expansion Systems
10.2.1.3. Auto Transfusion Devices
10.2.1.4. Others
10.2.2. Disposables & Consumables
10.3. Europe Transfusion Technology Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals
10.3.2. Blood Banks
10.3.3. Biotechnology & Pharmaceutical Companies
10.3.4. Others
10.4. Europe Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Transfusion Technology Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Transfusion Technology Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Transfusion Technology Market Value Forecast, by Product, 2016–2026
11.2.1. Instruments
11.2.1.1. Apheresis System & Multicomponent Collection Systems
11.2.1.2. Cell Processing Systems & Cell Expansion Systems
11.2.1.3. Auto Transfusion Devices
11.2.1.4. Others
11.2.2. Disposables & Consumables
11.3. Asia Pacific Transfusion Technology Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals
11.3.2. Blood Banks
11.3.3. Biotechnology & Pharmaceutical Companies
11.3.4. Others
11.4. Asia Pacific Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Transfusion Technology Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Transfusion Technology Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Transfusion Technology Market Value Forecast, by Product, 2016–2026
12.2.1. Instruments
12.2.1.1. Apheresis System & Multicomponent Collection Systems
12.2.1.2. Cell Processing Systems & Cell Expansion Systems
12.2.1.3. Auto Transfusion Devices
12.2.1.4. Others
12.2.2. Disposables & Consumables
12.3. Latin America Transfusion Technology Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals
12.3.2. Blood Banks
12.3.3. Biotechnology & Pharmaceutical Companies
12.3.4. Others
12.4. Latin America Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Transfusion Technology Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Transfusion Technology Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Transfusion Technology Market Value Forecast, by Product, 2016–2026
13.2.1. Instruments
13.2.1.1. Apheresis System & Multicomponent Collection Systems
13.2.1.2. Cell Processing Systems & Cell Expansion Systems
13.2.1.3. Auto Transfusion Devices
13.2.1.4. Others
13.2.2. Disposables & Consumables
13.3. Middle East & Africa Transfusion Technology Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals
13.3.2. Blood Banks
13.3.3. Biotechnology & Pharmaceutical Companies
13.3.4. Others
13.4. Middle East & Africa Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Transfusion Technology Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles
14.2.1. General Electric Healthcare
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Strategic Overview
14.2.1.5. Financial Overview
14.2.2. Haemonetics Corporation
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.2.3. SWOT Analysis
14.2.2.4. Strategic Overview
14.2.2.5. Financial Overview
14.2.3. TERUMO BCT
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Product Portfolio
14.2.3.3. SWOT Analysis
14.2.3.4. Strategic Overview
14.2.3.5. Financial Overview
14.2.4. B. Braun Melsungen AG
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Product Portfolio
14.2.4.3. SWOT Analysis
14.2.4.4. Strategic Overview
14.2.4.5. Financial Overview
14.2.5. Fresenius Kabi AG
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Product Portfolio
14.2.5.3. SWOT Analysis
14.2.5.4. Strategic Overview
14.2.5.5. Financial Overview
14.2.6. Medtronic
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Product Portfolio
14.2.6.3. SWOT Analysis
14.2.6.4. Strategic Overview
14.2.6.5. Financial Overview
14.2.7. LivaNova PLC
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Product Portfolio
14.2.7.3. SWOT Analysis
14.2.7.4. Strategic Overview
14.2.7.5. Financial Overview
14.2.8. Kawasumi Laboratories Inc.
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Product Portfolio
14.2.8.3. SWOT Analysis
14.2.8.4. Strategic Overview
14.2.8.5. Financial Overview
14.2.9. Lmb Technologie GmbH
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Product Portfolio
14.2.9.3. SWOT Analysis
14.2.9.4. Strategic Overview
14.2.9.5. Financial Overview
14.2.10. Miltenyi Biotec
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Product Portfolio
14.2.10.3. SWOT Analysis
14.2.10.4. Strategic Overview
14.2.10.5. Financial Overview
14.2.11. Asahi Kasei Medical Co., Ltd.
14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.11.2. Product Portfolio
14.2.11.3. SWOT Analysis
14.2.11.4. Strategic Overview
14.2.11.5. Financial Overview
14.2.12. Cerus Corporation
14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.12.2. Product Portfolio
14.2.12.3. SWOT Analysis
14.2.12.4. Strategic Overview
14.2.12.5. Financial Overview
Table 1: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 2: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 3: Global Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2015–2026
Table 4: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Region, 2017–2026
Table 5: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 6: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 7: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 8: North America Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 9: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 11: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 12: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 14: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 15: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 16: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 20: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 21: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 24: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026